Financhill
Back

Prime Medicine Stock Predictions

Prime Medicine Stock Forecast

  • Is Prime Medicine Stock Undervalued?
    The current Prime Medicine [PRME] share price is $3.98. The Score for PRME is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • PRME is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Prime Medicine Stock Go Up Next Year?

Data Unavailable

Prime Medicine Stock Rating

Data Unavailable

Prime Medicine Stock Price History

Is PRME stock going to rise?

  • The current trend is relatively stagnant and PRME is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
primemedicine.com

52-Week Data

52-Week High:
12.45
52-Week Low:
3.47

Prediction Charts

Market Cap:
477.72M
Price in USD:
3.98
Volume:
831.03K
Beta:
2.06

Technical Analysis

SMA50:
4.70
SMA100:
5.46
SMA200:
6.43
52-Wk Change:
-66.55%

Stock Predictions

  • Is Prime Medicine stock public?
    Yes, Prime Medicine is a publicly traded company.
  • What is the Prime Medicine stock quote today?
    The Prime Medicine stock price is 3.98 USD today.
  • How to buy Prime Medicine stock online?
    You can buy Prime Medicine shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-29 4.33 4.31 4.54 4.24
Aug-30 4.32 4.28 4.39 4.20
Sep-3 4.40 3.85 4.40 3.85
Sep-4 3.86 3.86 4.03 3.75
Sep-5 3.85 3.76 3.92 3.72
Sep-6 3.72 3.55 3.79 3.47
Sep-9 3.59 3.68 3.82 3.50
Sep-10 3.67 4.00 4.06 3.61
Sep-11 3.96 4.06 4.10 3.84
Sep-12 4.09 4.07 4.14 3.93
Sep-13 4.15 4.09 4.19 3.98
Sep-16 4.08 3.74 4.11 3.71
Sep-17 3.83 4.00 4.16 3.74
Sep-18 4.01 3.98 4.23 3.90

Prime Medicine Earnings

Data Unavailable

Prime Medicine Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.13 per share, an increase this year of $0.17 per share, and an increase next year of $0.21 per share.

* Prime Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.